FY2021โFY2024 ยท from SEC filings ยท hover any figure for its source
$2.2M
โ$1.3M
2021
$4.3M
โ$2.0M
2022
$7.9M
โ$2.9M
2023
$9.5M
โ$2.6M
2024
RevenueNet income โ beside revenue when positive, below the line when a loss
Metric
FY2021
FY2022
FY2023
FY2024
Income statement
Revenue
$2,164,951
$4,277,597
$7,866,304
$9,471,488
Cost of goods sold
$1,579,480
$3,578,172
$5,199,296
$5,866,062
Gross margin
27%
16%
34%
38%
Net income
-$1,264,701
-$1,995,342
-$2,865,288
-$2,631,186
Taxes paid
$0
$0
$0
$0
Balance sheet
Cash
$8,608
$1,201,649
$483,136
$147,797
Accounts receivable
$277,338
$667,399
$683,208
$448,812
Total assets
$935,913
$3,958,617
$2,145,446
$2,705,644
Short-term debt
$471,571
$1,000,000
$2,206,009
$1,869,993
Long-term debt
$290,100
$707,028
$2,173,796
$2,741,670
Total liabilities
$761,671
$1,707,028
$4,379,805
$4,611,663
Other
Headcount
โ
8
8
8
Figures as reported by the issuer in the filing shown on hover. Each yearโs pill shows the assurance level of its filed statements โ audited, reviewed (CPA review, less than an audit), or unaudited; no pill means the filing didnโt state one. Headcount is the filingโs point-in-time count, not a year-end average. Manually corrected figures are marked โCorrectedโ.
Source: SEC EDGARCIK 0001932398DEShare price $2.32Last synced Aug 17, 2026
About this data. Figures are compiled from public sources โ SEC EDGAR filings (Form C, C-AR, 1-A, 1-K) and funding-platform pages โ and may be delayed, incomplete, or restated by the issuer. Financial statements are as reported by the issuer; each year is labeled with its assurance level (audited / reviewed / unaudited). A valuation cap is the conversion ceiling of a SAFE or convertible note, not an agreed company valuation; post-money figures are computed as pre-money plus amount raised and are not a traded price. Crowdonomics is not a broker-dealer, funding portal, or investment adviser; nothing here is investment advice or an offer to sell securities. Verify all figures against the linked EDGAR filings.